Twist Bioscience Corp (TWST)
42.38
-0.82
(-1.91%)
USD |
NASDAQ |
May 10, 16:00
42.38
0.00 (0.00%)
After-Hours: 18:32
Twist Bioscience Revenue (TTM): 277.49M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 277.49M |
| December 31, 2023 | 262.36M |
| September 30, 2023 | 245.11M |
| June 30, 2023 | 235.47M |
| March 31, 2023 | 227.84M |
| December 31, 2022 | 215.79M |
| September 30, 2022 | 203.56M |
| June 30, 2022 | 184.21M |
| March 31, 2022 | 163.11M |
| December 31, 2021 | 146.19M |
| September 30, 2021 | 132.33M |
| June 30, 2021 | 126.82M |
| Date | Value |
|---|---|
| March 31, 2021 | 113.00M |
| December 31, 2020 | 101.10M |
| September 30, 2020 | 90.10M |
| June 30, 2020 | 73.40M |
| March 31, 2020 | 65.80M |
| December 31, 2019 | 60.06M |
| September 30, 2019 | 54.39M |
| June 30, 2019 | 47.06M |
| March 31, 2019 | 40.00M |
| December 31, 2018 | 32.61M |
| September 30, 2018 | 25.43M |
| June 30, 2018 | 20.49M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
47.06M
Minimum
Jun 2019
277.49M
Maximum
Mar 2024
151.26M
Average
139.26M
Median
Revenue (TTM) Benchmarks
| Tandem Diabetes Care Inc | 770.01M |
| Perspective Therapeutics Inc | 0.00 |
| Xtant Medical Holdings Inc | 91.30M |
| Asensus Surgical Inc | 8.577M |
| Catheter Precision Inc | 0.442M |